CS
RNTX

Candriam SCA’s Rein Therapeutics RNTX Stock Holding History

Candriam SCA’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,128
Closed -$28K – 922
2021
Q2 		$28K Buy
+1,128
New +$28.1K ﹤0.01% 853
2018
Q3 		– Sell
-7,500
Closed -$813K – 848
2018
Q2 		$813K Hold
7,500
– – 0.01% 646
2018
Q1 		$1.22M Hold
7,500
– – 0.02% 556
2017
Q4 		$1.58M Hold
7,500
– – 0.03% 501
2017
Q3 		$2.01M Hold
7,500
– – 0.04% 457
2017
Q2 		$1.67M Buy
+7,500
New +$1.65M 0.03% 495

Other funds holding RNTX

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return